Cargando…
Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma
To date no informative biomarkers exist to accurately predict presence of lymph node metastases (LNM) in esophageal adenocarcinoma (EAC). We studied the discriminative value of Olfactomedin 4 (OLFM4), an intestinal stem cell marker, in EAC. Patients who had undergone esophagectomy as single treatmen...
Autores principales: | Suzuki, Lucia, ten Kate, Fiebo J. C., Gotink, Annieke W., Stoop, Hans, Doukas, Michail, Nieboer, Daan, Spaander, Manon C. W., van Lanschot, Jan J. B., van Wijnhoven, Bas P. L., Koch, Arjun D., Bruno, Marco J., Looijenga, Leendert H. J., Biermann, Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613772/ https://www.ncbi.nlm.nih.gov/pubmed/31283789 http://dx.doi.org/10.1371/journal.pone.0219494 |
Ejemplares similares
-
Do pathologists agree with each other on the histological assessment
of pT1b oesophageal adenocarcinoma?
por: Gotink, Annieke W, et al.
Publicado: (2018) -
Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma
por: Ten Kate, Fiebo J.C., et al.
Publicado: (2017) -
Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case–control study
por: van Olphen, Sophie H., et al.
Publicado: (2016) -
Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer
por: Clemmensen, Stine N., et al.
Publicado: (2015) -
Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis
por: Janmaat, Vincent T., et al.
Publicado: (2017)